Clinical and epidemiological aspects of ulcerative colitis in the Irkutsk region

AIM: to study sociodemographic, clinical and epidemiological features in patients with ulcerative colitis in the Irkutsk region (Russia).

PATIENTS AND METHODS: the database of the Irkutsk IBD Center included 1,122 patients with ulcerative colitis (UC) registered from 01.01.2006 to 31.12.2019. The study is retrospective with a focus on the results of follow-up, check up and treatment in different periods of their disease (acute attack, chronic course, remission). Statistical analysis was performed according to the principles of the International Committee of Medical Journal Editors (ICMJE).

RESULTS: the incidence of inflammatory bowel disease in the Irkutsk Oblast over the previous 14 years has increased by 2.7 times, of ulcerative colitis — by 3.1 times and was 3.91 person-years per 100,000 population. The prevalence of UC was 68.5 per 100,000 population. The annual increase in new UC cases was 46.6 ± 8.2. Most patients had total lesion (68.4%) and moderate-to-severe disease (46.9%). Extra-intestinal manifestations (13.6%) were represented by skin lesions (40.7%). Body weight deficiency occurred in 9.9% in females and in 5.1% in males. The probability of colectomy was 1.4/100 patient-years (follow-up period was 7049.5 patient-years; n = 1122). Patients underwent urgent operations in 76.3%. Postoperative mortality was 1.03/100 patient-years (exposition time — 291.6 years, n = 3). Total mortality for the entire follow-up period was 1.8% — 0.34/100 patient-years (exposition time — 4440.8 years).

CONCLUSION: objective epidemiological data, clinical features and treatment options for patients with ulcerative colitis in long-term follow-up in the Irkutsk Oblast are presented. The results of such studies on a national scale can serve as a platform for further scientific research and planning of socio-economic programs.

1. Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643–654. doi: 10.1016/j.gtc.2020.07.005

2. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390(10114):2769– 2778. doi: 10.1016/S0140-6736(17)32448-0

3. Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1(4):307–316. doi: 10.1016/S2468-1253(16)30077-2

4. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7(3):260–270. doi: 10.1097/00054725-200108000-00013

5. Oli AK, Maidur RN, Hurkadli PS, et al. Incidence of inflammatory bowel disease: A single centre retrospective study. Arq Gastroenterol. 2022;59(3):345–351. doi: 10.1590/S0004-2803.202203000-63

6. Burisch J, Pedersen N, Cukovic-Cavka S, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCOEpiCom inception cohort. Gut. 2014;63(4):588–597.

7. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. doi: 10.1053/j.gastro.2011.10.001

8. Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942–951. doi: 10.3109/00365521.2015.1014407

9. Jess T, Gamborg M, Munkholm P, Sørensen TI. Overall and cause-specific mortality in ulcerative colitis: Meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102(3):609–617. doi: 10.1111/j.1572-0241.2006.01000.x

10. Belousova E.A., Abdulganieva D.I., Alexeeva O.P., et al. Social and demographic characteristics, features of disease course and treatment options of inflammatory bower disease in Russia: Results of two multicenter studies. Almanac of Clinical Medicine. 2018;46(5):445–463. (in Russ.). doi: 10.18786/2072-0505-2018-46-5-445-463

11. Kniazev O.V., Shkurko T.V., Kagramanova A.V., et al. Epidemiology of inflammatory bowel disease. State of the problem (review). Russian Journal of Evidence-Based Gastroenterology. 2020;9(2):66– 73. (in Russ.). doi: 10.17116/dokgastro2020902166

12. Gubonina I.V., Grinevich V.B., Tkachenko E.I., et al. Clinical and epidemiological characteristics and outcomes of inflammatory bowel diseases according to 8-year follow-up in a cohort of patients in the North-West region. Experimental and Clinical Gastroenterology. 2019;172(12):24–33. (in Russ.). doi: 10.31146/1682-8658-ecg172-12-24-33

13. Dolgushina A.I., Khusainova G.M., Vasilenko A.G., et al. Inflammatory bowel disease in the Chelyabinsk Region. Almanac of Clinical Medicine. 2019;47(6):511–517. (in Russ.). doi: 10.18786/2072-0505-2019-47-066

14. Ivashkin V.T., Shelygin Yu.A., Khalif I.L., et al. Clinical guide of Russian Association of Gastroenterology and Russian Association of Coloproctology on diagnostics and treatment of Crohn’s disease. Koloproktologia. 2017;2(60):7–29. (in Russ.).

15. Chashkova E.Yu., Korotaeva N.S., Pak V.E. Epidemiological data of patients with inflammatory diseases of the colon in Irkutsk and the Irkutsk region: Certificate of state registration of the database. No. 2015620082. 15.01.2015. (in Russ.).

16. Vlasov V.V. Introduction to evidence-based medicine. Moscow: Media Sfera; 2001. (in Russ.).

17. Zhao M, Gönczi L, Lakatos PL, Burisch J. The burden of inflammatory bowel disease in Europe in 2020. J Crohns Colitis. 2021;15(9):1573–1587. doi: 10.1093/ecco-jcc/jjab029

18. Global Burden of Disease Study. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30.